Project Details
Description
A prospective, randomized, active (warfarin) controlled, parallel-arm clinical trial to determine if patients with an On-X aortic valve can be maintained safely and effectively on the factor Xa inhibitor apixaban
| Status | Active |
|---|---|
| Effective start/end date | 10/1/20 → 9/1/23 |
Funding
- ARTIVION, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.